1. What Is the Pulmonary Artery Catheter Market?
The Pulmonary Artery Catheter Market comprises flow-directed balloon-tipped catheter systems inserted through central veins and advanced to the pulmonary artery to measure right heart and pulmonary haemodynamic parameters in critically ill patients. The market includes thermodilution PA catheters that measure cardiac output by cold indicator dilution and continuous thermodilution catheters with heated filament technology. It also includes specialty PA catheters with additional functions including continuous SvO2 monitoring and right ventricular ejection fraction measurement. These catheters are used by critical care physicians, cardiac anaesthesiologists, and cardiac surgeons to guide fluid management, vasopressor titration, and cardiac output optimisation. Patients include those with cardiogenic shock, severe heart failure, high-risk cardiac surgery, and pulmonary hypertension evaluation. Market scope covers pulmonary artery flotation catheters and their introduction sheaths, and excludes central venous catheters without PA pressure measurement capability, non-invasive cardiac output monitoring systems, and implantable pulmonary artery pressure sensors.
2. Pulmonary Artery Catheter Market Size & Forecast
3. Emerging Technologies
- PA catheter miniaturisation is advancing new-generation catheter designs with smaller French profiles that reduce insertion trauma while maintaining measurement accuracy for thermodilution cardiac output, PA pressure, and PAWP determination. Growing critical care interest in.
- Wireless implantable PA pressure sensors are advancing as an outpatient alternative to catheter-based PA pressure monitoring for advanced heart failure management, providing physicians with continuous PA pressure data. Growing industry adoption of this technology is motivating development.
- Combined right heart catheterisation and endomyocardial biopsy PA catheter platforms are advancing the ability to perform diagnostic haemodynamics measurement and tissue sampling from a single catheter insertion, reducing procedure burden. Growing industry adoption of this technology is motivating development.
- AI-assisted haemodynamic interpretation software is advancing integration with PA catheter continuous monitoring data streams to provide real-time clinical decision alerts when cardiac output. Growing industry adoption of this technology is motivating development.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Peripherally Inserted Central Catheter Picc Line Market.
4. Key Market Opportunity
A key opportunity in the Pulmonary Artery Catheter Market is the sustained use of diagnostic right heart catheterisation for pulmonary hypertension evaluation and management as growing PAH awareness and targeted therapy development expand the diagnostic population. Growing physician awareness of pulmonary arterial hypertension as a treatable and life-threatening condition is increasing referral rates to designated PH specialist centres where diagnostic right heart catheterisation is mandated before targeted therapy initiation. Expanding PAH drug therapy approvals including combination therapy regimens and new drug classes requiring pre-treatment haemodynamic confirmation are creating a growing procedural demand for diagnostic PA catheterisation at PH centres managing expanding patient populations. PA catheter manufacturers that provide specialist-grade catheters optimised for PH diagnostic workflows, with stable pressure measurement across the procedure duration and compatibility with dedicated PH haemodynamic monitoring software, are positioned to capture growing diagnostic procedure volume.
5. Top Companies in the Pulmonary Artery Catheter Market
The following organisations hold leading positions in the Pulmonary Artery Catheter Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Edwards Lifesciences
- ICU Medical
- Becton Dickinson
- Teleflex
- B. Braun Melsungen
- Nihon Kohden
- Smiths Medical
- Argon Medical Devices
- Arrow International (Teleflex)
- Biosensors International
6. Market Segmentation
The Pulmonary Artery Catheter Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Catheter Type | Standard Thermodilution PA Catheter Intermittent Thermodilution Pacing PA Catheter Continuous Output PA Catheter CCO Continuous Thermodilution CCO with Continuous SvO2 Specialty PA Catheter Right Ventricular EF Catheter Balloon Flotation Diagnostic Catheter |
| By Measurement Parameter | Cardiac Output Thermodilution Intermittent Thermodilution CO Continuous Thermodilution CO Pulmonary Artery Pressure PAWP Occlusion Pressure Pulmonary Venous Resistance PVR Calculated Parameter Venous Oxygen Saturation Mixed Venous SvO2 |
| By Application | Cardiogenic Shock Management Low Output Cardiogenic Shock Vasoplegic Shock Differentiation Cardiac Surgery Monitoring On-Pump Cardiac Surgery High-Risk Cardiac Valve Surgery Pulmonary Hypertension Evaluation Diagnostic Right Heart Catheterisation Heart Failure Management Decompensated HF Guided Therapy |
| By End User | Hospitals Cardiac ICU Programmes Cardiac Surgery Units Pulmonary Hypertension Centres PH Diagnostic Programmes Heart Failure Programmes Advanced HF and Transplant Centres |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Pulmonary Artery Catheter Market trajectory over the forecast period:
Continuous Cardiac Output PA Catheters Are Replacing Intermittent Thermodilution in High-Risk Cardiac Surgery Monitoring Programmes.Cardiac anaesthesiologists and cardiac surgery teams managing complex valve. Aortic surgical cases are increasing continuous output PA catheter adoption as real-time cardiac output trend monitoring during bypass provides more actionable haemodynamic data than periodic cold-water bolus measurements. Edwards Lifesciences continued commercial availability of the Vigilance II continuous cardiac output monitor compatible with its CCO PA catheter systems in 2024. This provides cardiac anaesthesiologists with real-time cardiac index and SvO2 trending capabilities during complex cardiac surgical procedures.
Right Heart Catheterisation Remains the Diagnostic Gold Standard for Pulmonary Hypertension Classification and Treatment Selection.Pulmonary hypertension specialists at designated PH centres continue performing diagnostic right heart catheterisation with PA catheters to measure pulmonary vascular resistance and confirm PAH diagnosis before initiating targeted pharmacological therapy. As non-invasive echocardiographic assessment cannot reliably measure pulmonary haemodynamics. European and North American pulmonary hypertension guidelines published in 2024 reaffirmed diagnostic right heart catheterisation with PA pressure measurement as the mandatory diagnostic step in PAH classification, reinforcing continued procedural demand. PH specialist centres regardless of alternative technology availability.
Minimally Invasive Cardiac Output Monitoring Has Substituted PA Catheters in Lower-Risk Surgical and ICU Populations.Intensivists and anaesthesiologists managing patients who do not require right heart pressure data are adopting minimally invasive cardiac output monitoring platforms including arterial waveform analysis. Transthoracic bioreactance as alternatives to PA catheter insertion in moderate-risk haemodynamic monitoring scenarios. Published consensus statements from critical care societies in 2024 updated guidance on PA catheter indications, recommending reservation for specific cardiogenic. Pulmonary hypertension, complex cardiac surgery indications where right heart pressure data informs management decisions not available from less invasive monitoring.
For related market intelligence, see the Central Venous Catheter Market.
8. Segmental Analysis
By catheter type, standard thermodilution PA catheters dominated the Pulmonary Artery Catheter Market in 2025, driven by continued deployment at cardiac surgery programmes and high-acuity ICU settings where right heart pressure measurement informs treatment decisions. Cardiac anaesthesiologists managing complex cardiac surgery continue specifying standard thermodilution PA catheters as the reference haemodynamic tool where definitive right heart pressure and cardiac output data is required. Continuous cardiac output PA catheters are the fastest-growing type, driven by cardiac surgery adoption where real-time output trending during complex valve and aortic procedures provides more actionable data than intermittent bolus thermodilution. Cardiac anaesthesiologists at high-volume valve and aortic surgery centres are increasing CCO catheter specification as evidence demonstrates improved haemodynamic management with continuous trending compared with periodic intermittent measurement.
By application, cardiogenic shock management dominated the Pulmonary Artery Catheter Market in 2025, reflecting the continued role of invasive haemodynamic monitoring in guiding mechanical circulatory device selection and vasopressor titration. Critical care cardiologists managing cardiogenic shock continue inserting PA catheters to differentiate low-output cardiogenic from vasoplegic profiles and guide device titration where clinical parameters alone are insufficient. Pulmonary hypertension evaluation is the fastest-growing application, driven by increasing PAH specialist programme development and guideline mandates for diagnostic right heart catheterisation before targeted therapy initiation. Pulmonary hypertension specialists are increasing right heart catheterisation volumes as PAH awareness improves referral rates and expanding targeted therapy options require diagnostic haemodynamic confirmation before initiating complex treatment regimens.
9. Regional Analysis
Regional demand patterns across the Pulmonary Artery Catheter Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Pulmonary Artery Catheter Market in 2025, holding 46.0% of the global market. The region's dominance reflects the large number of complex cardiac surgery procedures and cardiac ICU programmes at United States and Canadian academic medical centres, well-developed pulmonary hypertension specialist centre infrastructure, and established reimbursement for invasive haemodynamic monitoring procedures. A large network of pulmonary hypertension programmes at academic medical centres in North America generates consistent diagnostic right heart catheterisation procedure demand as PAH awareness, referral rates, and treatment pathway adherence improve. Advanced heart failure and cardiac transplant programmes at academic centres in the United States continue using PA catheters for haemodynamic-guided decompensated heart failure management and pre-transplant evaluation, creating a stable specialty catheter demand base.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 7.00% during the forecast period. Growing pulmonary hypertension awareness and expanding specialist programme development at major tertiary hospitals in China, Japan, South Korea, and Australia are increasing diagnostic right heart catheterisation volumes and creating demand for PA catheter systems at newly designated PH centres. Increasing critical care capacity and complex cardiac surgery programme development at tertiary hospitals in the region are expanding the number of procedures requiring invasive haemodynamic monitoring, creating demand for PA catheters in ICU and cardiac surgery indications. Government investment in pulmonary hypertension diagnostic and treatment infrastructure in China and South Korea is improving patient access to specialist PH evaluation including right heart catheterisation, expanding procedural volumes at designated PH diagnostic centres.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Pulmonary Artery Catheter Market was valued at USD 345.37 Mn in 2025 and is projected to reach USD 470.74 Mn by 2034, growing at a CAGR of 3.50% over the 2026–2034 forecast period.
The Pulmonary Artery Catheter Market is projected to grow at a CAGR of 3.50% from 2026 to 2034.
North America accounted for the largest share of the Pulmonary Artery Catheter Market in 2025, holding 46.0% of the global market.
The leading companies in the Pulmonary Artery Catheter Market include Edwards Lifesciences, ICU Medical, Becton Dickinson, Teleflex, B. Braun Melsungen, Nihon Kohden, Smiths Medical, Argon Medical Devices, Arrow International (Teleflex), Biosensors International.
Continuous cardiac output pa catheters are replacing intermittent thermodilution in high-risk cardiac surgery monitoring programmes.
By catheter type, standard thermodilution PA catheters dominated the Pulmonary Artery Catheter Market in 2025, driven by continued deployment at cardiac surgery programmes and high-acuity ICU settings where right heart pressure measurement informs treatment decisions.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.